ANXA2 and rheumatoid arthritis: In this study, we discovered that ANXA2 knockdown results in upregulation of DEGs that were abundant in various pathways such as ECM-receptor interaction, lysosome, rheumatoid arthritis, phagosome, and PI3K-AKT signaling pathway.